Assessment of Pulmonary Specialty Physicians’ Approach to Advanced Care Planning in Patients With Chronic Pulmonary Diseases

Overview

To understand current practices of pulmonary physicians in relation to Advanced Care Planning (ACP) in order to develop future disease-specific tools that will improve patient-physician communication about ACP.

Full Title of Study: “Assessment of Pulmonary Specialty Physicians’ Approach to Advanced Care Planning in Patients With Chronic Pulmonary Diseases”

Study Type

  • Study Type: Observational
  • Study Design
    • Time Perspective: Retrospective
  • Study Primary Completion Date: June 2014

Detailed Description

The study will be a retrospective, observational study and analysis of charts of patients with Chronic Obstructive Pulmonary Disease (COPD) or pulmonary fibrosis treated as outpatients at the Ohio State University Wexner Medical Center Lung Center. Using pre-existing data, we will determine if advanced care planning has been discussed with these patients and record this information. For all patients, we will gather data about specific demographic and clinical characteristics that may have contributed to the presence or absence of these discussions. The study is descriptive in nature and is not powered to detect a difference between the two groups. Instead, we aim to describe the characteristics most frequently associated with advanced care planning discussion in these two particular groups. Potential subjects will be identified with assistance from the Information Warehouse. After identification, data will be abstracted from pre-existing data in the electronic medical record and collected in a coded fashion for each subject. Each subject will be assigned an anonymous subject identification number and all links to identifying information will be destroyed prior to analysis. All study data will be stored on a secure password protected data base to which only study personnel will have access.

Arms, Groups and Cohorts

  • COPD, pulmonary fibrosis
    • observational study, no interventions to be administered

Clinical Trial Outcome Measures

Primary Measures

  • Record the presence or absence of Advanced Care Planning (ACP) discussions with patients with advanced lung disease
    • Time Frame: Last two years
    • This is a descriptive study which will retrospectively review whether Advanced Care Planning discussions have been documented in the medical records of patients with chronic obstructive pulmonary disease or pulmonary fibrosis. Using pre-existing data, we will determine if Advanced Care Planning has been discussed with these patients and record this information.

Participating in This Clinical Trial

Inclusion Criteria

1. Patients who are between 18 and 88 years of age who have been diagnosed with a physician diagnosis of COPD based on at least one of the following:

  • clinical history – a documented history of COPD, emphysema, or chronic bronchitis. – pulmonary function results – defined as an forced expiratory volume in one second to forced vital capacity ratio (FEV1/FVC) less than 0.7 2. Patients who are between 18 and 88 years of age and have been diagnosed with pulmonary fibrosis based on the following: – Subpleural, basal predominance of parenchymal abnormality on high resolution computed tomography (HRCT) – Reticular abnormality on HRCT – Honeycombing without traction bronchiectasis on HRCT – Absence of features that are inconsistent with usual interstitial pneumonia (UIP) pattern OR – UIP based on surgical lung biopsy Exclusion Criteria:

  • Age < 18 years or > 88 years – Prisoners – Pregnant patients

Gender Eligibility: All

Minimum Age: 18 Years

Maximum Age: 88 Years

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • Jennifer McCallister MD
  • Provider of Information About this Clinical Study
    • Sponsor-Investigator: Jennifer McCallister MD, Associate Professor-Clinical – Ohio State University
  • Overall Official(s)
    • Jennifer W McCallister, M.D, Principal Investigator, The Ohio State University Wexner Medical Center

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.